miércoles, 20 de noviembre de 2019

First CRISPR treatment for blood diseases shows early benefits - STAT

First CRISPR treatment for blood diseases shows early benefits - STAT

Daily Recap

First CRISPR treatment for blood diseases shows early benefits in two patients

By SHARON BEGLEY AND ADAM FEUERSTEIN


JONATHAN ARMSTRONG/WELLCOME
The encouraging data offer hope that genome editing might one day offer a safe, durable cure for sickle cell disease and beta thalassemia.

No hay comentarios: